This chemical is primarily utilized in the development of pharmaceutical compounds, particularly as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring a benzoic acid core with a sulfamoyl and ethynylphenyl group, makes it valuable for designing molecules with potential therapeutic effects. It is often explored in research targeting enzyme inhibition, especially in the context of inflammatory and autoimmune diseases. Additionally, its unique chemical properties allow it to be used in the study of molecular interactions and drug-receptor binding mechanisms, aiding in the discovery of new drugs.